Enrique A. Conterno
2013
In 2013, Enrique A. Conterno earned a total compensation of $3M as Senior Vice President and President Diabetes Business Unit at Lilly Eli & Co, a 23% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $88,167 |
|---|---|
| Non-Equity Incentive Plan | $699,376 |
| Salary | $680,658 |
| Stock Awards | $1,500,000 |
| Other | $40,840 |
| Total | $3,009,041 |
Conterno received $1.5M in stock awards, accounting for 50% of the total pay in 2013.
Conterno also received $88.2K of change in pension value and nonqualified deferred compensation earnings, $699.4K in non-equity incentive plan, $680.7K in salary and $40.8K in other compensation.
Rankings
In 2013, Enrique A. Conterno's compensation ranked 2,535th out of 12,286 executives tracked by ExecPay. In other words, Conterno earned more than 79.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,535 out of 12,286 | 79th |
Division Manufacturing | 833 out of 4,612 | 82nd |
Major group Chemicals And Allied Products | 222 out of 1,462 | 85th |
Industry group Drugs | 147 out of 1,156 | 87th |
Industry Pharmaceutical Preparations | 125 out of 890 | 86th |
Source: SEC filing on March 21, 2016.
Conterno's colleagues
We found four more compensation records of executives who worked with Enrique A. Conterno at Lilly Eli & Co in 2013.
2013
John Lechleiter
Lilly Eli & Co
Chief Executive Officer
2013
Derica Rice
Lilly Eli & Co
Chief Financial Officer
2013
Jan Lundberg
Lilly Eli & Co
Executive Vice President, Science and Technology and President, Lilly Research Laboratories
2013
Michael Harrington
Lilly Eli & Co